July 29, 2016 6:04 PM ET


Company Overview of Elsevier B.V.

Company Overview

Elsevier B.V. publishes science, health, and technology online and offline literature. It publishes books, periodicals, journals, and Web based digital solutions in the areas of business/management science/accounting, chemistry, computer science/security, criminal justice, earth and environmental sciences, economics/finance, energy/power, engineering, life sciences, materials science, mathematics and statistics, media technology, physics and astronomy, psychology, security, and social sciences. It offers Elsevier Clinical Solutions, an evidence-based clinical decision solution that provides solutions in the areas of academic education, clinical practice, drug information, patient engagement,...

Radarweg 29

Amsterdam,  1043 NX


Founded in 1880


31 20 485 3911


31 20 485 2457

Key Executives for Elsevier B.V.

Chief Executive Officer
Age: 56
Chief Financial Officer
Executive Vice President of Operations
Age: 64
Senior Vice President and General Counsel
Managing Director of Global Sales & Customer Marketing group - Science & Technology Division
Compensation as of Fiscal Year 2016.

Elsevier B.V. Key Developments

Elsevier Announces Management Changes

Elsevier appointed Professor Paolo G. Camici, MD, as the new Editor-in-Chief of the International Journal of Cardiology. Professor Camici will take over from Professor Andrew J.S. Coats (Joint Academic Vice-President, Monash University, Australia and University of Warwick, United Kingdom) on September 1, 2016. Having worked for many years in prestigious universities and hospitals both in the UK and Italy, with a wealth of experience as Consultant, Clinician Scientist, Program Director, Lecturer, Examiner, Society Fellow, Working Group Chairman and member of multiple Editorial Boards, Professor Camici's current position is Professor of Cardiology and Consultant Cardiologist at the Vita-Salute University San Raffaele, in Milan, Italy. He is also Director of the University's Cardiology Training program.

WuXi AppTec Adopts Reaxys and Reaxys Medicinal Chemistry to Support Research and Expansion Ambitions

Elsevier announced that WuXi AppTec has adopted Reaxys and Reaxys Medicinal Chemistry. More than 3,500 chemists across WuXi will use the products to support their synthetic chemistry and medicinal chemistry research, giving them quick and easy access to chemistry information. The deal also supports WuXi's ambitions to expand and move into newer areas, such as medicinal chemistry, and to build strong technology platforms. By extracting and indexing more than 500 million experimental details, the Reaxys platform provides the most robust system for searching published, reviewed data, along with the ability to utilize data in the manner that most suits researchers' workflows and needs. Reaxys, with its recent expansion of chemistry data and capabilities, encompassing content from over 16,000 periodicals, provides the deepest and richest fact-base of experimentally measured chemistry data. Reaxys Medicinal Chemistry offers access to data from a vast repository of peer-reviewed journal articles and patents, and is interoperable with Reaxys. Both solutions also integrate with technology from other vendors, allowing WuXi to incorporate its own data and content. Coupled with the flexibility of its search function and the way results are presented, this will enable chemists to more effectively examine the reactions and relationships between different compounds, supporting WuXi's continued growth in medicinal chemistry, and its novel pharma R&D business. The five-year agreement between Elsevier and WuXi took effect in December 2015, and consists of an unlimited license for both solutions that covers all WuXi sites. Established for over 13 years, WuXi AppTec has operations in both China and the United States, with over 3 million square feet of laboratory and manufacturing space.

Elsevier to Launch Mobile-Optimized myHealthTalent.com for Healthcare Professionals and Recruiters

Elsevier announced that it is launching a new, upgraded career resource for healthcare professionals. The new tool, myHealthTalent.com, replaces Elsevier's current job search resource and reflects a more personalized site for both job seekers and recruiters. MyHealthTalent.com offers job seekers the ability to personalize their career search through a mobile-friendly platform that is optimized for any device, allowing users to initiate, save and set alerts for searches based on individualized criteria such as location, position and desired salary. In order to offer the best possible user experience to their job seekers, Elsevier has partnered with Madgex to power their new online recruitment platform. For recruiters, myHealthTalent.com provides the ability to set search and screening requirements by location, specialty, qualifications and experience level, among other search criteria, to secure the desired talent. Also, in-house recruiters and recruiting agencies can use myHealthTalent.com to help fill positions with the most qualified talent in a variety of practice settings, from physician offices and surgery centers to the country's most prestigious hospitals and institutions. The site covers more than 80 specialties, including cardiology, emergency medicine, gastroenterology, internal medicine, nursing, obstetrics/gynecology, pediatrics, surgery and urology.

Similar Private Companies By Industry

Company Name Region
@hand Communications BV Europe
121interaction Europe
4DM Services BV Europe
7write BV Europe
Abbink Communications Group B.V. Europe

Recent Private Companies Transactions

May 17, 2016
Social Science Electronic Publishing, Inc.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Elsevier B.V., please visit www.elsevier.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.